Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies

Journal of Immunology

Volumn 176, Issue 9, 2006, Pages 5671-5681

  Capozzo, Alejandra V E ^a,c   Ramírez, Karina ^a   Polo, John M ^b   Ulmer, Jeffrey ^b   Barry, Eileen M ^a   Levine, Myron M ^a   Pasetti, Marcela F ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Vetia SA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; MATERNAL ANTIBODY; MEASLES VACCINE; NEUTRALIZING ANTIBODY; SINDBIS VIRUS DNA MEASLES VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BONE MARROW; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MOUSE; NEWBORN; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; RELIABILITY; SINDBIS VIRUS; SPLEEN; SYNCYTIUM; T LYMPHOCYTE; TH1 CELL;

EID: 33645990610     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.9.5671     Document Type: Article

References (62)

1. Henao-Restrepo, A.-M., P. Strebel, H. E. John, M. Birmingham, and J. Bilous. 2003. Experience in global measles control, 1990-2001. J. Infect. Dis. 187(Suppl. 1): S15-S21.
2. Tapia, M. D., S. O. Sow, S. Medina-Moreno, Y. Lim, M. F. Pasetti, K. Kotloff, and M. M. Levine. 2005. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. Am. J. Trop. Med. Hyg. 73: 26-31.
3. Pasetti, M. F., E. M. Barry, G. Losonsky, M. Singh, S. M. Medina-Moreno, J. M. Polo, J. Ulmer, H. Robinson, M. B. Sztein, and M. M. Levine. 2003. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats. J. Virol. 77: 5209-5217.
4. Schlereth, B., P.-G. Germann, V. ter, Meulen, and S. Niewiesk. 2000. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection. J. Gen. Virol. 81: 1321-1325.
5. Stittelaar, K. J., R. L. de Swart, H. W. Vos, G. van Amerongen, N. Sixt, T. F. Wild, and A. D. Osterhaus. 2002. Priming of measles virus-specific humoral- and cellular-immune responses in macaques by DNA vaccination. Vaccine 20: 2022-2026.
6. Pan, C.-H., A. Valsamakis, T. Colella, N. Nair, R. J. Adams, F. P. Polack, C. E. Greer, S. Perri, J. M. Polo, and D. E. Griffin. 2005. Inaugural article: modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc. Natl. Acad. Sci. USA 102: 11581-11588.
7. Polack, F. P., S. H. Lee, S. Permar, E. Manyara, H. G. Nousari, Y. Jeng, F. Mustafa, A. Valsamakis, R. J. Adams, H. L. Robinson, and D. E. Griffin. 2000. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat. Med. 6: 776-781.
8. Hassett, D. E., J. Zhang, M. Slifka, and J. L. Whitton. 2000. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol. 74: 2620-2627.
9. Siegrist, C.-A., M. Pihlgren, C. Tougne, S. M. Efler, M. L. Morris, M. J. AlAdhami, D. W. Cameron, C. L. Cooper, J. Heathcote, H. L. Davis, and P.-H. Lambert. 2004. Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine 23: 615-622.
10. Pertmer, T. M., A. E. Oran, J. M. Moser, C. A. Madorin, and H. L. Robinson. 2000. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein. J. Virol. 74: 7787-7793.
11. Manickan, E., Z. Yu, and B. T. Rouse. 1997. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J. Clin. Invest. 100: 2371-2375.
12. Premenko-Lanier, M., P. A. Rota, G. Rhodes, D. Verhoeven, D. H. Barouch, N. W. Lerche, N. L. Letvin, W. J. Bellini, and M. B. McChesney. 2003. DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. Virology 307: 67-75.
13. Siegrist, C. A., C. Barrios, X. Martinez, C. Brandt, M. Berney, M. Cordova, J. Kovarik, and P. H. Lambert. 1998. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 28: 4138-4148.
14. Premenko-Lanier, M., P. Rota, G. Rhodes, W. Bellini, and M. McChesney. 2004. Prior DNA vaccination does not interfere with the live-attenuated measles vaccine. Vaccine 22: 762-765.
15. Premenko-Lanier, M., P. A. Rota, G. H. Rhodes, W. J. Bellini, and M. B. McChesney. 2004. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J. Infect. Dis. 189: 2064-2071.
16. Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162: 1036-1042.
17. Song, M. K., C. J. Vindurampulle, A. V. Capozzo, J. Ulmer, J. M. Polo, M. F. Pasetti, E. M. Barry, and M. M. Levine. 2005. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. J. Virol. 79: 9854-9861.
18. de Swart, R. L., S. Yüksel, and A. D. Osterhaus. 2005. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J. Virol. 79: 11547-11551.
19. Polo, J. M., J. P. Gardner, Y. Ji, B. A. Belli, D. A. Driver, S. Sherrill, S. Perri, M. A. Liu, and T. W. Dubensky, Jr. 2000. Alphavirus DNA and particle replicons for vaccines and gene therapy. Dev. Biol. 104: 181-185.
20. Leitner, W. W., L. N. Hwang, M. J. deVeer, A. Zhou, R. H. Silverman, B. R. Williams, T. W. Dubensky, H. Ying, and N. P. Restifo. 2003. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9: 33-39.
21. Leitner, W. W., L. N. Hwang, E. S. Bergmann-Leitner, S. E. Finkelstein, S. Frank, and N. P. Restifo. 2004. Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine 22: 1537-1544.
22. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829.
23. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564.
24. Siegrist, C. A. 2000. Vaccination in the neonatal period and early infancy. Int. Rev. Immunol. 19: 195-219.
25. Van de Ferre, P. 2003. Transfer of antibody via mother's milk. Vaccine 21: 3374-3376.
26. de Souza, V. A., C. S. Pannuti, L. M. Sumita, and H. F. de Andrade, Jr. 1997. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J. Med. Virol. 52: 275-279.
27. Pannuti, C. S., R. J. Morello, J. C. de Moraes, S. P. Curti, A. M. Afonso, M. C. Camargo, and V. A. de Souza. 2004. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic. Clin. Diagn. Lab. Immunol. 11: 119-122.
28. Cutts, F. T. 1993. Module 7: Measles-The Immunological Basis for Immunization Series. Geneva: World Health Organization.
29. Ward, B. J., S. Aouchiche, N. Martel, F. M. Bertley, N. Bautista-Lopez, B. Serhir, and S. Ratnam. 1999. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. Diagn. Microbiol. Infect. Dis. 33: 147-152.
30. Capozzo, A. V., L. Cuberos, M. M. Levine, and M. F. Pasetti. 2004. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers. Infect. Immun. 72: 4637-4646.
31. Bertley, F. M., S. A. Ibrahim, M. Libman, and B. J. Ward. 2004. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination. Vaccine 23: 444-449.
32. Wong-Chew, R. M., J. A. Beeler, S. Audet, and J. I. Santos. 2003. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine. J. Med Virol. 70: 276-280.
33. Polack, F. P., S. J. Hoffman, G. Crujeiras, and D. E. Griffin. 2003. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat. Med. 9: 1209-1213.
34. Osterhaus, A., G. van Amerongen, and R. van Binnendijk. 1998. Vaccine strategies to overcome maternal antibody mediated inhibition of measles vaccine. Vaccine 16: 1479-1481.
35. Manz, R. A., A. E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23: 367-386.
36. Slifka, M. K., and R. Ahmed. 1996. Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection. Ann. NY Acad. Sci. 797: 166-176.
37. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
38. McHeyzer-Williams, M. G., and R. Ahmed. 1999. B cell memory and the long-lived plasma cell. Curr. Opin. Immunol. 11: 172-179.
39. Slifka, M. K., M. Matloubian, and R. Ahmed. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69: 1895-1902.
40. Martinez, X., C. Brandt, F. Saddallah, C. Tougne, C. Barrios, F. Wild, G. Dougan, P. H. Lambert, and C. A. Siegrist. 1997. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA 94: 8726-8731.
41. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158: 2278-2284.
42. Barrios, C., P. Brawand, M. Berney, C. Brandt, P. H. Lambert, and C. A. Siegrist. 1996. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26: 1489-1496.
43. Barrios, C., C. Brandt, M. Berney, P. H. Lambert, and C. A. Siegrist. 1996. Partial correction of the Th2/Th1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol. 26: 2666-2670.
44. Schlender, J., J.-J. Schnorr, P. Spielhofer, T. Cathomen, R. Cattaneo, M. A. Billeter, V. ter, Meulen, and S. Schneider-Schaulies. 1996. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc. Natl. Acad. Sci. USA 93: 13194-13199.
45. Niewiesk, S., I. Eisenhuth, A. Fooks, J. C. Clegg, J. J. Schnorr, S. Schneider-Schaulies, and V. ter Meulen. 1997. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J. Virol. 71: 7214-7219.
46. Schneider-Schaulies, S., S. Niewiesk, J. Schneider-Schaulies, and V. ter Meulen. 2001. Measles virus induced immunosuppression: targets and effector mechanisms. Curr. Mol. Med. 1: 163-181.
47. Moss, W. J., M. O. Ota, and D. E. Griffin. 2004. Measles: immune suppression and immune responses. Int. J. Biochem. Cell Biol. 36: 1380-1385.
48. Weidmann, A., A. Maisner, W. Garten, M. Seufert, V. ter Meulen, and S. Schneider-Schaulies. 2000. Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro. J. Virol. 74: 1985-1993.
49. Schallert, N., M. Pihlgren, J. Kovarik, C. Roduit, C. Tougne, P. Bozzotti, G. Del Giudice, C.-A. Siegrist, and P.-H. Lambert. 2002. Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur. J. Immunol. 32: 752-760.
50. Crowe, J. E., Jr. 2001. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin. Infect. Dis. 33: 1720-1727.
51. Siegrist, C. A. 2003. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21: 3406-3412.
52. Pihlgren, M., N. Schallert, C. Tougne, P. Bozzotti, J. Kovarik, A. Fulurija, M. Kosco-Vilbois, P.-H. Lambert, and C.-A. Siegrist. 2001. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur. J. Immunol. 31: 939-946.
53. Pihlgren, M., M. Friedli, C. Tougne, A. F. Rochat, P. H. Lambert, and C. A. Siegrist. 2006. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J. Immunol. 176: 165-172.
54. Slifka, M. K., J. K. Whitmire, and R. Ahmed. 1997. Bone marrow contains virus-specific cytotoxic T lymphocytes. Blood 90: 2103-2108.
55. Gans, H., R. DeHovitz, B. Forghani, J. Beeler, Y. Maldonado, and A. M. Arvin. 2003. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21: 3398-3405.
56. Merz, D. C., A. Scheid, and P. W. Choppin. 1980. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J. Exp. Med. 151: 275-288.
57. Polack, F. P., P. G. Auwaerter, S. H. Lee, H. C. Nousari, A. Valsamakis, K. M. Leiferman, A. Diwan, R. J. Adams, and D. E. Griffin. 1999. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat. Med. 5: 629-634.
58. Polack, F. P., S. J. Hoffman, W. J. Moss, and D. E. Griffin. 2003. Differential effects of priming with DNA vaccines encoding the hemagglutinin and/or fusion proteins on cytokine responses after measles virus challenge. J. Infect. Dis. 187: 1794-1800.
59. Permar, S. R., S. A. Klumpp, K. G. Mansfield, A. A. Carville, D. A. Gorgone, M. A. Lifton, J. E. Schmitz, K. A. Reimann, F. P. Polack, D. E. Griffin, and N. L. Letvin. 2004. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J. Infect. Dis. 190: 998-1005.
60. + lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J. Virol. 77: 4396-4400.
61. Bautista-López, N., B. J. Ward, E. Mills, D. McCormick, N. Martel, and S. Ratnam. 2000. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 18: 1393-1401.
62. Ward, B. J., N. Boulianne, S. Ratnam, M.-C. Guiot, M. Couillard, and G. De Serres. 1995. Cellular immunily in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferalive responses despite limited serum antibody production after revaccinalion. J. Infect. Dis. 172: 1591-1595.